Today, the FDA approved the first drug to treat adults & pediatric patients 12 years of age & older who weigh at least 35 kilograms with post-transplant cytomegalovirus (CMV) infection/disease that does not respond to available antiviral treatment for CMV. https://t.co/ZsxsEb2oJr
Bravo to the University of Maryland Medical Center Transplant Pharmacy team! Swipe through the pictures to learn about our wonderful colleagues. #transplantteamtuesday#txpharm#innovation#CPA
Using HCV NAT + organs in HCV naive recipients? 🤩
Concerned about access to HCV treatment? 💊🤑
Check out our experience @HopkinsMedicine! All patients had coverage and most started treatment in the first month post-transplant.
https://t.co/YX0GRQcPSw
Confused by someone labeled "immunocompromised" and their infection risks? Same. So with guidance of our ID Mentors @PrathitKulkarni, @Cortes_Penfield, & @transplantID - @KatieBedardMD, Charmaine Mutucumarana and I created an Infections in Immunocompromised Hosts Schema
KDIGO is pleased to share the Top Ten Takeaways for Clinicians and Patients from the KDIGO 2020 Diabetes Management in CKD Guideline.
Download these and other resources from the KDIGO Diabetes in CKD Guideline website: https://t.co/kTvlEWhx4Q.
#Diabetes#CKD
Loving weekends in Baltimore!
If you are a PGY1 interested in a PGY2 in transplant, consider @umresfelrx ! You will be joining a large resident class in a great city with some pretty cool preceptors. #twitteRx#txpharm#PharmRes
Autoimmune hepatitis pts have ⬇️ post-transplant survival compared to PBC & PSC
HUGE AIH cohort (2515 pts): ⬆️death from infection (esp fungal) & graft loss
#livertwitter: Should we ⬇️IS in pre-transplant AIH? ⬆️after? Change fungal ppx? What do you do?
https://t.co/DWqZ09bBhv
Need a quick refresher on a fundamental liver topic?
Check out the Quick Tips section on Liver Fellow Network!
Topics include:
Hepatic Encephalopathy https://t.co/RcoT58fEvd
Esophageal Varices https://t.co/Vxr1qn5niM
Ascites https://t.co/DoZ7qG0W7b
+ many more!
#livertwitter
Do you switch to calcineurin inhibitor (CNI) to mTOR to minimize risk of chronic renal failure?
Answer first before cheating! https://t.co/Fmqn2kM1Lm
#livertwitter